Carregant...

Utility of adjuvant systemic therapy in melanoma

The lack of effective drugs in stage IV melanoma has impacted the effectiveness of adjuvant therapies in stage II/III disease. To date, chemotherapy, immunostimulants and vaccines have been used with minimal success. Interferon (IFN) has shown an effect on relapse-free survival (RFS) in several clin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Eggermont, A. M. M., Testori, A., Marsden, J., Hersey, P., Quirt, I., Petrella, T., Gogas, H., MacKie, R. M., Hauschild, A.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2712588/
https://ncbi.nlm.nih.gov/pubmed/19617295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdp250
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!